Hemophilia Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: H970A48D3D4AEN
Market Monitor Global

Abstracts

Hemophilia is a rare, inherited disorder in which blood doesn’t clot normally due to the lack of sufficient blood clotting factor. Clotting factor is a protein required for blood clotting to occur normally. These proteins work with platelets i.e. small blood cell fragments that form in the bone marrow, to help the blood clot. Hemophilia is passed from parents to children through genes.

This report contains market size and forecasts of Hemophilia Therapeutics in Global, including the following market information:

Global Hemophilia Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hemophilia Therapeutics market was valued at 9756 million in 2021 and is projected to reach US$ 13580 million by 2028, at a CAGR of 4.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hemophilia A Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hemophilia Therapeutics include Bayer AG, Pfizer, Inc., Novo Nordisk A/S, Baxter International Inc., Biogen Idec, Inc., Genetics Institute, Alpha Therapeutics Corporation, Expression Therapeutics and Swedish Orphan Biovitrum AB.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemophilia Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hemophilia Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hemophilia Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Hemophilia A
• Hemophilia B
• Hemophilia C

Global Hemophilia Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hemophilia Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Ambulatory Surgical Centers

Global Hemophilia Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hemophilia Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hemophilia Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hemophilia Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer AG
• Pfizer, Inc.
• Novo Nordisk A/S
• Baxter International Inc.
• Biogen Idec, Inc.
• Genetics Institute
• Alpha Therapeutics Corporation
• Expression Therapeutics
• Swedish Orphan Biovitrum AB.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hemophilia Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hemophilia Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEMOPHILIA THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Hemophilia Therapeutics Market Size: 2021 VS 2028
2.2 Global Hemophilia Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hemophilia Therapeutics Players in Global Market
3.2 Top Global Hemophilia Therapeutics Companies Ranked by Revenue
3.3 Global Hemophilia Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Hemophilia Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hemophilia Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hemophilia Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Hemophilia Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hemophilia Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hemophilia Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Hemophilia A
  4.1.3 Hemophilia B
  4.1.4 Hemophilia C
4.2 By Type - Global Hemophilia Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Hemophilia Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Hemophilia Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Hemophilia Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hemophilia Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Ambulatory Surgical Centers
5.2 By Application - Global Hemophilia Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Hemophilia Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Hemophilia Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Hemophilia Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hemophilia Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Hemophilia Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Hemophilia Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Hemophilia Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Hemophilia Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hemophilia Therapeutics Revenue, 2017-2028
  6.3.2 US Hemophilia Therapeutics Market Size, 2017-2028
  6.3.3 Canada Hemophilia Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Hemophilia Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hemophilia Therapeutics Revenue, 2017-2028
  6.4.2 Germany Hemophilia Therapeutics Market Size, 2017-2028
  6.4.3 France Hemophilia Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Hemophilia Therapeutics Market Size, 2017-2028
  6.4.5 Italy Hemophilia Therapeutics Market Size, 2017-2028
  6.4.6 Russia Hemophilia Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Hemophilia Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Hemophilia Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hemophilia Therapeutics Revenue, 2017-2028
  6.5.2 China Hemophilia Therapeutics Market Size, 2017-2028
  6.5.3 Japan Hemophilia Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Hemophilia Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Hemophilia Therapeutics Market Size, 2017-2028
  6.5.6 India Hemophilia Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hemophilia Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Hemophilia Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Hemophilia Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hemophilia Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Hemophilia Therapeutics Market Size, 2017-2028
  6.7.3 Israel Hemophilia Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Hemophilia Therapeutics Market Size, 2017-2028
  6.7.5 UAE Hemophilia Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bayer AG
  7.1.1 Bayer AG Corporate Summary
  7.1.2 Bayer AG Business Overview
  7.1.3 Bayer AG Hemophilia Therapeutics Major Product Offerings
  7.1.4 Bayer AG Hemophilia Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Bayer AG Key News
7.2 Pfizer, Inc.
  7.2.1 Pfizer, Inc. Corporate Summary
  7.2.2 Pfizer, Inc. Business Overview
  7.2.3 Pfizer, Inc. Hemophilia Therapeutics Major Product Offerings
  7.2.4 Pfizer, Inc. Hemophilia Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Pfizer, Inc. Key News
7.3 Novo Nordisk A/S
  7.3.1 Novo Nordisk A/S Corporate Summary
  7.3.2 Novo Nordisk A/S Business Overview
  7.3.3 Novo Nordisk A/S Hemophilia Therapeutics Major Product Offerings
  7.3.4 Novo Nordisk A/S Hemophilia Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Novo Nordisk A/S Key News
7.4 Baxter International Inc.
  7.4.1 Baxter International Inc. Corporate Summary
  7.4.2 Baxter International Inc. Business Overview
  7.4.3 Baxter International Inc. Hemophilia Therapeutics Major Product Offerings
  7.4.4 Baxter International Inc. Hemophilia Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Baxter International Inc. Key News
7.5 Biogen Idec, Inc.
  7.5.1 Biogen Idec, Inc. Corporate Summary
  7.5.2 Biogen Idec, Inc. Business Overview
  7.5.3 Biogen Idec, Inc. Hemophilia Therapeutics Major Product Offerings
  7.5.4 Biogen Idec, Inc. Hemophilia Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Biogen Idec, Inc. Key News
7.6 Genetics Institute
  7.6.1 Genetics Institute Corporate Summary
  7.6.2 Genetics Institute Business Overview
  7.6.3 Genetics Institute Hemophilia Therapeutics Major Product Offerings
  7.6.4 Genetics Institute Hemophilia Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Genetics Institute Key News
7.7 Alpha Therapeutics Corporation
  7.7.1 Alpha Therapeutics Corporation Corporate Summary
  7.7.2 Alpha Therapeutics Corporation Business Overview
  7.7.3 Alpha Therapeutics Corporation Hemophilia Therapeutics Major Product Offerings
  7.7.4 Alpha Therapeutics Corporation Hemophilia Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Alpha Therapeutics Corporation Key News
7.8 Expression Therapeutics
  7.8.1 Expression Therapeutics Corporate Summary
  7.8.2 Expression Therapeutics Business Overview
  7.8.3 Expression Therapeutics Hemophilia Therapeutics Major Product Offerings
  7.8.4 Expression Therapeutics Hemophilia Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Expression Therapeutics Key News
7.9 Swedish Orphan Biovitrum AB.
  7.9.1 Swedish Orphan Biovitrum AB. Corporate Summary
  7.9.2 Swedish Orphan Biovitrum AB. Business Overview
  7.9.3 Swedish Orphan Biovitrum AB. Hemophilia Therapeutics Major Product Offerings
  7.9.4 Swedish Orphan Biovitrum AB. Hemophilia Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Swedish Orphan Biovitrum AB. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hemophilia Therapeutics Market Opportunities & Trends in Global Market
Table 2. Hemophilia Therapeutics Market Drivers in Global Market
Table 3. Hemophilia Therapeutics Market Restraints in Global Market
Table 4. Key Players of Hemophilia Therapeutics in Global Market
Table 5. Top Hemophilia Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hemophilia Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hemophilia Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hemophilia Therapeutics Product Type
Table 9. List of Global Tier 1 Hemophilia Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hemophilia Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hemophilia Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hemophilia Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hemophilia Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hemophilia Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hemophilia Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hemophilia Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hemophilia Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hemophilia Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hemophilia Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hemophilia Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hemophilia Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hemophilia Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hemophilia Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hemophilia Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Bayer AG Corporate Summary
Table 31. Bayer AG Hemophilia Therapeutics Product Offerings
Table 32. Bayer AG Hemophilia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer, Inc. Corporate Summary
Table 34. Pfizer, Inc. Hemophilia Therapeutics Product Offerings
Table 35. Pfizer, Inc. Hemophilia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Novo Nordisk A/S Corporate Summary
Table 37. Novo Nordisk A/S Hemophilia Therapeutics Product Offerings
Table 38. Novo Nordisk A/S Hemophilia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Baxter International Inc. Corporate Summary
Table 40. Baxter International Inc. Hemophilia Therapeutics Product Offerings
Table 41. Baxter International Inc. Hemophilia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Biogen Idec, Inc. Corporate Summary
Table 43. Biogen Idec, Inc. Hemophilia Therapeutics Product Offerings
Table 44. Biogen Idec, Inc. Hemophilia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Genetics Institute Corporate Summary
Table 46. Genetics Institute Hemophilia Therapeutics Product Offerings
Table 47. Genetics Institute Hemophilia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Alpha Therapeutics Corporation Corporate Summary
Table 49. Alpha Therapeutics Corporation Hemophilia Therapeutics Product Offerings
Table 50. Alpha Therapeutics Corporation Hemophilia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Expression Therapeutics Corporate Summary
Table 52. Expression Therapeutics Hemophilia Therapeutics Product Offerings
Table 53. Expression Therapeutics Hemophilia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Swedish Orphan Biovitrum AB. Corporate Summary
Table 55. Swedish Orphan Biovitrum AB. Hemophilia Therapeutics Product Offerings
Table 56. Swedish Orphan Biovitrum AB. Hemophilia Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hemophilia Therapeutics Segment by Type in 2021
Figure 2. Hemophilia Therapeutics Segment by Application in 2021
Figure 3. Global Hemophilia Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hemophilia Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hemophilia Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hemophilia Therapeutics Revenue in 2021
Figure 8. By Type - Global Hemophilia Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hemophilia Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hemophilia Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hemophilia Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hemophilia Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hemophilia Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hemophilia Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hemophilia Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hemophilia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer AG Hemophilia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer, Inc. Hemophilia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novo Nordisk A/S Hemophilia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Baxter International Inc. Hemophilia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Biogen Idec, Inc. Hemophilia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Genetics Institute Hemophilia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Alpha Therapeutics Corporation Hemophilia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Expression Therapeutics Hemophilia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Swedish Orphan Biovitrum AB. Hemophilia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)